For Immediate Release
January 26, 2021
AABB Appoints Linda S. Barnes as Vice President of Biotherapies
Bethesda, Md. — AABB announced today the appointment of Linda S. Barnes, DrPHc, MHA, RAC (RAPS), as its Vice President, Biotherapies. Barnes has served in the role of Biotherapies Strategy Lead throughout the past six months, helping to advance the Association’s biotherapies-related offerings and spearheading a strategic analysis of opportunities in biotherapies.
“Biotherapies is an important aspect of AABB’s community and scope,” said Debra BenAvram, AABB’s CEO. “Linda’s knowledge and experience make her an ideal match to lead AABB’s efforts as the Association continues to expand its offerings in the biotherapies realm.”
Barnes has supported AABB as an independent consultant to the Global Services Division throughout the past several years and as the Biotherapies Strategy Lead. Her diverse experience in cellular therapies and other biotherapies includes a history working in commercial biotech, where she led technical operations, scale-up and nursing education. She brings extensive clinical trial management experience in domestic and international settings. As a seasoned executive leader, Barnes brings a systems-thinking approach to complex adaptive problems.
“As a devoted AABB member, I am honored to officially be joining AABB as Vice President of Biotherapies,” said Barnes. “I think of blood transfusion as the foundational cellular therapy. For this reason, AABB’s legacy can naturally facilitate the fast-growing field of advanced ‘living’ therapies, by helping patients, partners and health systems adopt these new treatments.”
Barnes maintains her board certification in regulatory affairs and volunteers as a qualified Baldrige Examiner for organizational performance excellence (NIST). Her Bachelor’s degree in Biology (Whitman College) is augmented by a master’s in health service administration (University of Washington). She is currently in the dissertation phase of her doctorate in public health leadership (University of Illinois—Chicago). Her language skills include intermediate French, Italian and Chinese (Mandarin).
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.